Quaker Houghton (KWR)
(Delayed Data from NYSE)
$161.60 USD
+1.57 (0.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $161.47 -0.13 (-0.08%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$161.60 USD
+1.57 (0.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $161.47 -0.13 (-0.08%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Zacks News
Quaker Chemical (KWR) Q4 Earnings and Sales Top Estimates
by Zacks Equity Research
Sales related to Houghton and Norman Hay drive Quaker Chemical's (KWR) top line in Q4.
Earnings Preview: Quaker Chemical (KWR) Q4 Earnings Expected to Decline
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DQ vs. KWR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DQ vs. KWR: Which Stock Is the Better Value Option?
DQ or KWR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DQ vs. KWR: Which Stock Is the Better Value Option?
DQ or KWR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DQ vs. KWR: Which Stock Is the Better Value Option?
Quaker Chemical (KWR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 11.43% and 0.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Quaker Chemical (KWR) Q3 Earnings Expected to Decline
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Chemical Stocks Poised to Outshine Q3 Earnings Estimates
by Anindya Barman
The impact of demand weakness due to the U.S.-China trade war might be reflected on the performance of chemical companies in Q3.
New Strong Buy Stocks for October 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
3 Reasons Why Quaker Chemical (KWR) Is a Great Growth Stock
by Zacks Equity Research
Quaker Chemical (KWR) possesses solid growth attributes, which could help it handily outperform the market.
New Strong Sell Stocks for August 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Quaker Chemical (KWR) Tops Q2 Earnings Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 0.65% and -8.07%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Quaker Chemical (KWR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quaker Chemical (KWR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DQ vs. KWR: Which Stock Is the Better Value Option?
by Zacks Equity Research
DQ vs. KWR: Which Stock Is the Better Value Option?
Quaker Chemical (KWR) Q4 Earnings Top Estimates, Sales Lag
by Anindya Barman
Quaker Chemical (KWR) gained from higher volumes and selling prices as well as favorable product mix in Q4.
Quaker Chemical (KWR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Higher Prices Help Mosaic (MOS) Beat Earnings in Q4?
by Anindya Barman
Our proven model shows that Mosaic (MOS) is likely to beat estimates in Q4.
DQ vs. KWR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DQ vs. KWR: Which Stock Is the Better Value Option?
Can Albemarle (ALB) Maintain Earnings Beat Streak in Q4?
by Anindya Barman
Albemarle (ALB) will likely gain from higher expected volumes and pricing in its lithium business in Q4.
Why the Earnings Surprise Streak Could Continue for Quaker Chemical (KWR)
by Zacks Equity Research
Quaker Chemical (KWR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CF Industries (CF) to Post Q4 Earnings: What's in the Offing?
by Anindya Barman
CF Industries (CF) will likely benefit from higher prices of nitrogen fertilizers in Q4.
Near-Term Prospects Cloudy for Specialty Chemical Stocks
by Zacks Equity Research
Trade tensions and raw material cost inflation pose as headwinds for the chemical specialty industry.
What's in the Cards for Huntsman (HUN) in Q4 Earnings?
by Anindya Barman
Huntsman's (HUN) results are likely to be impacted by seasonality in the fourth quarter.
Cabot's (CBT) Q1 Earnings Miss, Sales Surpass Estimates
by Zacks Equity Research
Cabot's (CBT) performance in Q1 hurt by weaker environment in China along with softer automotive demand and customer inventory destocking. The company lowers adjusted EPS view for fiscal 2019.